Acadia wins Nuplazid patent case, extending protection to 2038, as JP Morgan boosts price target ahead of key appeal on the ‘740 COM patent.
Latest Ratings for ACAD
DateFirmActionFromTo Mar 2022Cantor FitzgeraldMaintainsOverweight Mar 2022Goldman SachsMaintainsNeutral Mar 2022MizuhoMaintainsNeutral